Opus Genetics Appoints Rob Gagnon as Chief Financial Officer
1. Opus Genetics appoints Rob Gagnon as Chief Financial Officer. 2. Gagnon has raised over $2 billion in capital for biotech firms. 3. He is expected to drive growth in clinical pipeline and regulatory milestones. 4. Opus develops gene therapies for inherited retinal diseases (IRDs). 5. The company's lead candidates are in ongoing clinical trials.